These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23656655)

  • 1. Cinacalcet for cardiovascular disease in patients undergoing dialysis.
    Locatelli F; Pontoriero G; Tentori F
    N Engl J Med; 2013 May; 368(19):1843. PubMed ID: 23656655
    [No Abstract]   [Full Text] [Related]  

  • 2. Cinacalcet for cardiovascular disease in patients undergoing dialysis.
    Tripepi G
    N Engl J Med; 2013 May; 368(19):1843-4. PubMed ID: 23656657
    [No Abstract]   [Full Text] [Related]  

  • 3. Cinacalcet for cardiovascular disease in patients undergoing dialysis.
    Goldsmith DJ; Lamb EJ
    N Engl J Med; 2013 May; 368(19):1843. PubMed ID: 23656656
    [No Abstract]   [Full Text] [Related]  

  • 4. Cinacalcet for cardiovascular disease in patients undergoing dialysis.
    Urena-Torres P; Prié D; Souberbielle JC
    N Engl J Med; 2013 May; 368(19):1842-3. PubMed ID: 23656654
    [No Abstract]   [Full Text] [Related]  

  • 5. Cinacalcet for cardiovascular disease in patients undergoing dialysis.
    Chertow GM; Parfrey PS
    N Engl J Med; 2013 May; 368(19):1844-5. PubMed ID: 23656653
    [No Abstract]   [Full Text] [Related]  

  • 6. Trials in kidney disease--time to EVOLVE.
    Perkovic V; Neal B
    N Engl J Med; 2012 Dec; 367(26):2541-2. PubMed ID: 23121375
    [No Abstract]   [Full Text] [Related]  

  • 7. Secondary hyperparathyroidism in chronic dialysis patients.
    Gai M; Cantaluppi V
    Blood Purif; 2012; 34(3-4):211; author reply 212. PubMed ID: 23095735
    [No Abstract]   [Full Text] [Related]  

  • 8. Cinacalcet hydrochloride in chronic kidney disease-mineral bone disorder.
    Yokoyama K
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1405-8. PubMed ID: 19696214
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of cinacalcet in a patient on long-term dialysis with end-stage renal failure and refractory secondary hyperparathyroidism.
    Dorsch O
    Nephrol Dial Transplant; 2007 Feb; 22(2):637-40. PubMed ID: 17095580
    [No Abstract]   [Full Text] [Related]  

  • 10. Mineral metabolism: Should cinacalcet be used in patients who are not on dialysis?
    Cannata-Andía JB; Fernández-Martín JL
    Nat Rev Nephrol; 2009 Jun; 5(6):307-8. PubMed ID: 19474823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary hyperparathyroidism in chronic dialysis patients: results of the Italian FARO survey on treatment and mortality.
    Brancaccio D; Cozzolino M; Cannella G; Messa P; Bonomini M; Cancarini G; Caruso MR; Cascone C; Costanzo AM; di Luzio Paparatti U; Mazzaferro S;
    Blood Purif; 2011; 32(2):124-32. PubMed ID: 21625082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cinacalcet: benefit and cost.
    Cohen E
    Nephrol Dial Transplant; 2008 Apr; 23(4):1460; author reply 1460. PubMed ID: 18065795
    [No Abstract]   [Full Text] [Related]  

  • 13. Cinacalcet cost and utility in dialysis patients.
    Cohen E; Uribarri J
    Semin Dial; 2005; 18(4):353-4. PubMed ID: 16076364
    [No Abstract]   [Full Text] [Related]  

  • 14. Cinacalcet for secondary hyperparathyroidism in hemodialysis recipients.
    Owda AK; Alam MG; Kumar J
    N Engl J Med; 2004 Jul; 351(2):188-9; author reply 188-9. PubMed ID: 15247361
    [No Abstract]   [Full Text] [Related]  

  • 15. Cinacalcet: new drug. Secondary hyperparathyroidism: where are the clinical data?
    Prescrire Int; 2006 Jun; 15(83):90-3. PubMed ID: 16764095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cinacalcet, fetuin-A and interleukin-6.
    Marino A; Giotta N
    Nephrol Dial Transplant; 2008 Apr; 23(4):1460-1; author reply 1461-2. PubMed ID: 18065786
    [No Abstract]   [Full Text] [Related]  

  • 17. Regression of parathyroid gland swelling by treatment with cinacalcet.
    Terawaki H; Nakano H; Takeguchi F; Hasegawa T; Nakayama M; Okazaki M; Hosoya T
    Nephrol Dial Transplant; 2009 Feb; 24(2):690-1; author reply 691-2. PubMed ID: 18987257
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan.
    Iseki K
    Expert Opin Pharmacother; 2008 Mar; 9(4):601-10. PubMed ID: 18312161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Six cases of successful cinacalcet cessation in haemodialysis patients treated for secondary hyperparathyroidism.
    Jean G; Chazot C; Charra B
    Nephrol Dial Transplant; 2007 Jul; 22(7):2102-3. PubMed ID: 17395648
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview.
    Chertow GM; Pupim LB; Block GA; Correa-Rotter R; Drueke TB; Floege J; Goodman WG; London GM; Mahaffey KW; Moe SM; Wheeler DC; Albizem M; Olson K; Klassen P; Parfrey P
    Clin J Am Soc Nephrol; 2007 Sep; 2(5):898-905. PubMed ID: 17702710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.